|
|
|
2018 |
AFT024 |
2012 |
CFC034 |
BFC012 |
MC3T3PA6 |
NIH3T3 |
|
|---|---|---|---|---|---|---|---|
|
Flk2/Flt3-L |
++ |
++ |
++ |
++ |
++ |
+ |
+ |
|
cKit-L |
++++ |
++++ |
++++ |
++++ |
++++ |
++ |
++++ |
|
LIF |
++ |
++ |
++ |
++ |
++++ |
+ |
- |
|
Il-6 |
+++ |
+ |
+++ |
+++ |
++++ |
+ |
- |
|
Il-7 |
- |
- |
- |
- |
- |
- |
- |
|
Il-11 |
+++ |
++++ |
+++ |
+ |
+++ |
+ |
++ |
|
G-CSF |
+ |
+ |
+ |
+ |
+ |
- |
- |
|
GM-CSF |
++ |
+ |
+ |
+ |
+ |
- |
- |
|
IGF-1 |
+++ |
++++ |
+++ |
++++ |
++++ |
+ |
+ |
|
TGF-b |
++++ |
++++ |
++++ |
++++ |
++++ |
+++ |
+++ |
|
MIP-1a |
- |
- |
- |
- |
- |
- |
- |
|
MPL-L |
+ |
++ |
+++ |
+ |
+++ |
+ |
+++ |
Random hexamer primed cDNAs were synthesized using reverse transcriptase SuperScript II (Life Technologies) from cell line RNA. PCR amplification with appropriate primers was done for 30R. Results were interpreted from intensity of ethidium bromide staining of amplified products.